These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 35303112

  • 1. Conspicuity and muscle-invasiveness assessment for bladder cancer using VI-RADS: a multi-reader, contrast-free MRI study to determine optimal b-values for diffusion-weighted imaging.
    Delli Pizzi A, Mastrodicasa D, Taraschi A, Civitareale N, Mincuzzi E, Censi S, Marchioni M, Primiceri G, Castellan P, Castellucci R, Cocco G, Chiacchiaretta P, Colasante A, Corvino A, Schips L, Caulo M.
    Abdom Radiol (NY); 2022 May; 47(5):1862-1872. PubMed ID: 35303112
    [Abstract] [Full Text] [Related]

  • 2. Bladder cancer: do we need contrast injection for MRI assessment of muscle invasion? A prospective multi-reader VI-RADS approach.
    Delli Pizzi A, Mastrodicasa D, Marchioni M, Primiceri G, Di Fabio F, Cianci R, Seccia B, Sessa B, Mincuzzi E, Romanelli M, Castellan P, Castellucci R, Colasante A, Schips L, Basilico R, Caulo M.
    Eur Radiol; 2021 Jun; 31(6):3874-3883. PubMed ID: 33211143
    [Abstract] [Full Text] [Related]

  • 3. Integrating radiomics with the vesical imaging-reporting and data system to predict muscle invasion of bladder cancer.
    Wang W, Li W, Wang K, Wu J, Qiu J, Zhang Y, Zhang X, Wang H, Wang X.
    Urol Oncol; 2023 Jun; 41(6):294.e1-294.e8. PubMed ID: 36526525
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Bladder MRI with deep learning-based reconstruction: a prospective evaluation of muscle invasiveness using VI-RADS.
    Zhang X, Wang Y, Xu X, Zhang J, Sun Y, Hu M, Wang S, Li Y, Chen Y, Zhao X.
    Abdom Radiol (NY); 2024 May; 49(5):1615-1625. PubMed ID: 38652125
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Amide Proton Transfer-Weighted MRI and Diffusion-Weighted Imaging in Bladder Cancer: A Complementary Tool to the VI-RADS.
    Kong L, Wen Z, Cai Q, Lin Y, Chen Y, Cao W, Li M, Qian L, Chen J, Guo Y, Wang H.
    Acad Radiol; 2024 Feb; 31(2):564-571. PubMed ID: 37821347
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Vesical Imaging Reporting and Data System (VI-RADS): Are the individual MRI sequences equivalent in diagnostic performance of high grade NMIBC and MIBC?
    Gmeiner J, Garstka N, Helbich TH, Shariat SF, Baltzer PA.
    Eur J Radiol; 2021 Sep; 142():109829. PubMed ID: 34252867
    [Abstract] [Full Text] [Related]

  • 20. Performance of VI-RADS in predicting muscle-invasive bladder cancer after transurethral resection: a single center retrospective analysis.
    Chai JL, Roller LA, Liu X, Lan Z, Mossanen M, Silverman SG, Shinagare AB.
    Abdom Radiol (NY); 2024 May; 49(5):1593-1602. PubMed ID: 38502214
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.